Penwood is an essay newsletter by a commercial leader who advises biopharma and MedTech companies on launch strategy and AI adoption. Each issue argues a specific point, such as why launches miss forecasts, why commercial teams stall on AI, or why connected-device data decisions belong before regulatory clearance, backed by industry studies and the author's experience at Novartis and Sanofi.

A governance student's academic assignments framed as board papers on Fisher & Paykel Healthcare, covering strategy, risk and compliance, and the Theranos collapse. The posts are structured, cite sources, and offer analysis of corporate governance, though they are framed as coursework rather than polished commentary.

Metatalks is a new online publication covering AI, biotech and medtech trends, with recent issues summarising news items such as virtual power plants, OpenAI research on cross-occupation AI use, and a benchmark for AI music detectors. The excerpts are largely rewrites of reporting from other outlets and papers, with some useful detail but little original analysis.

Josh Adams, an engineer and entrepreneur, shares lessons from building medical and industrial products, including engineering insights, business lessons, and personal projects. The newsletter doubles as a working journal and a channel for speaking, acquisition, and company updates.